1. Bispecific Antibodies Progression in Malignant Melanoma
   Juan Tang et al, 2022, Frontiers in Pharmacology CrossRef
2. Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
   G. de Jong et al, 2021, Cancer Immunology, Immunotherapy CrossRef